Hi Peter, I agree with you abt the teva's optimistic tone. But from the fda's point of view, what's the hurry? There is a generic and they will be closely watching for any immunogenicity issues for at least some time like 6months to an yr. I feel they won't take addn risk by approving teva's now.
do u follow IRWD? Any thoughts on their results today?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.